4//SEC Filing
Salentine Thomas J Jr 4
Accession 0000950170-24-110997
CIK 0001802255other
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 5:48 PM ET
Size
7.9 KB
Accession
0000950170-24-110997
Insider Transaction Report
Form 4
Salentine Thomas J Jr
Director10% Owner
Transactions
- Award
Class B Common Stock
2024-09-27+24,400,702→ 24,400,702 total(indirect: By LLC)→ Class A Common Stock (24,400,702 underlying) - Purchase
Class A Common Stock
2024-09-27$14.00/sh+35,714$499,996→ 35,714 total
Footnotes (2)
- [F1]Represents shares purchased pursuant to a directed share program in connection with the Issuer's initial public offering.
- [F2]Represents shares of Class B common stock issued pursuant to the Agreement and Plan of Merger, dated as of September 27, 2024 (the "Merger Agreement"), by and among Guardian Pharmacy Services, Inc. (the "Issuer"), Guardian Merger Corp., a wholly owned subsidiary of the Issuer ("Merger Sub"), and Guardian Pharmacy, LLC, providing for the merger of Merger Sub with and into Guardian Pharmacy, LLC. As a result of the merger and pursuant to the Merger Agreement, each issued and outstanding common unit of Guardian Pharmacy, LLC (other than common units held by Guardian Investor, Inc.) was converted into one share of Class B common stock and the right to receive $1.02 in cash. The shares of Class B common stock issued will automatically convert into shares of Class A common stock on a one-for-one basis in four equal tranches on each of March 28, 2025, September 27, 2025, March 28, 2026 and September 27, 2026.
Documents
Issuer
Guardian Pharmacy Services, Inc.
CIK 0001802255
Entity typeother
Related Parties
1- filerCIK 0002037899
Filing Metadata
- Form type
- 4
- Filed
- Sep 30, 8:00 PM ET
- Accepted
- Oct 1, 5:48 PM ET
- Size
- 7.9 KB